References
Brown PJ, Oho AUID, Zhong J, Frood R, Currie S, Gilbert A, et al. Prediction of outcome in anal squamous cell carcinoma using radiomic feature analysis of pre-treatment FDG PET-CT. Eur J Nucl Med Mol Imaging. 2019;46:2790–9.
Sridhara R, Johnson JR, Justice R, Keegan P, Chakravarty A, Pazdur R. Review of oncology and hematology drug product approvals at the US Food and Drug Administration between July 2005 and December 2007. J Natl Cancer Inst. 2010;102:230–43.
Collins GS, Reitsma JB, Altman DG, Moons KG. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMJ. 2015;350:g7594.
Author information
Authors and Affiliations
Contributions
All the authors contribute to the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The author declare that they have no conflicts of interest.
Ethical approval
Not applicable.
Additional information
This article is part of the Topical Collection on Letter to the Editor
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Li, X., Xia, Z. & Li, W. Radiomic feature analysis of pre-treatment FDG PET-CT for predicting outcome in anal squamous cell carcinoma. Eur J Nucl Med Mol Imaging 47, 2733–2734 (2020). https://doi.org/10.1007/s00259-020-04802-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-020-04802-1